Johns Hopkins University’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-453,433
Closed -$42M 18
2024
Q2
$42M Sell
453,433
-318
-0.1% -$28.5K 1.68% 10
2024
Q1
$43.1M Hold
453,751
1.68% 10
2023
Q4
$40.5M Buy
453,751
+314,270
+225% +$23.3M 1.71% 10
2023
Q3
$10.2M Hold
139,481
0.56% 10
2023
Q2
$11.6M Hold
139,481
0.65% 7
2023
Q1
$10.6M Sell
139,481
-621,384
-82% -$51.6M 0.66% 7
2022
Q4
$63.2M Buy
760,865
+282,800
+59% +$22.9M 3.69% 7
2022
Q3
$37.9M Buy
478,065
+268,065
+128% +$22.6M 2.3% 6
2022
Q2
$15.6M Buy
+210,000
New +$15.8M 1.52% 6

Other funds holding XBI

Johns Hopkins University's XBI Position: Q3 2024 in Review

Johns Hopkins University sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 453,433 shares — an estimated $42M sold.

Johns Hopkins University first reported a position in XBI in Q2 2022 and held it in 9 quarters. The position peaked at $63.2M in Q4 2022. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

  • Johns Hopkins University reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
  • Johns Hopkins University sold 453,433 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $42M.
  • Johns Hopkins University first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 9 quarters.
  • Johns Hopkins University's State Street SPDR S&P Biotech ETF position peaked at $63.2M in Q4 2022.
  • 769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Johns Hopkins University's 13F filing for Q3 2024, filed 14 Nov 2024.